Fred Hassan's Trading History
| BBIOBridgeBio Pharma | Jun 24, 2026 | Director | Uninformative Buy | ― | $2.24M | |
| PGENPrecigen | Mar 16, 2026 | Director | Uninformative Buy | 252.15K | $8.63M | |
| COCPCocrystal Pharma | Oct 30, 2025 | Director | Uninformative Buy | 500.00K | $1.38M | |
| RXDXPrometheus Biosciences | Jun 16, 2023 | ― | Uninformative Sell | ― | $0.00 | |
| AMGNAmgen | May 07, 2020 | Director | Uninformative Buy | ― | $4.28M | |
| TWXTime Warner Inc | Jun 18, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| BHCBausch Health Companies | Sep 03, 2013 | Director | Informative Buy | 5.05M | $442.55K | |
| AVPAvon Products | Mar 01, 2011 | ― | Informative Buy | 172.48K | $274.84K | |
| MRKMerck & Company | Nov 04, 2009 | Chairman & CEO, Director | Uninformative Sell | ― | $0.00 | |
| EYPTEyePoint Pharmaceuticals | ― | Director | ― | ― |
You May Also Like
Fred Hassan insider profile FAQ
What is the percentage of profitable transactions made by Fred Hassan?
The percentage of profitable transactions made by Fred Hassan is 25%.
What is the average return per transaction made by Fred Hassan?
The average return per transaction made by Fred Hassan is -33.00%.
What stocks does Fred Hassan hold?
Fred Hassan holds: BBIO, EYPT, TWX, PGEN, COCP, RXDX, AMGN, MRK, BHC, AVP stocks.
What was Fred Hassan's most profitable transaction?
Fred Hassan’s most profitable transaction was an Informative Buy of AMGN stock on August 20, 2015. The return on the trade was 10.30%.
What is Fred Hassan's role in BridgeBio Pharma?
Fred Hassan's role in BridgeBio Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.